Outcomes of Enterobacter bloodstream infection in hospitalized children
Background. Enterobacter spp. has emerged as a major cause of nosocomial infections in children and adults, and may carry chromosomal AmpC β-lactamases that limits the choice of appropriate antibiotics. The antimicrobial treatment strategies for and outcomes of Enterobacter bacteremia in children have not been well described.
Methods. Multicenter, retrospective cohort study of patients 2 18 years admitted with monomicrobial Enterobacter spp. bloodstream infection at The Children's Hospital of Philadelphia, Johns Hopkins Children's Medical Center and Mayo Clinic Children's Hospital. Comprehensive chart review was performed to collect clinical and demographic data on all patients. Antibacterial exposure was recorded daily for 30 days and classified by antimicrobial class and whether combination therapy was used. Descriptive analysis included medians for continuous variables and percentages for categorical data.
Results 
